- Home
- JBTM vs TECH Comparison
JBTM vs TECH Comparison
Compare JBTM & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBTM
- TECH
- Stock Information
- Founded
- JBTM 1994
- TECH 1976
- Country
- JBTM United States
- TECH United States
- Employees
- JBTM N/A
- TECH N/A
- Industry
- JBTM
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JBTM
- TECH Health Care
- Exchange
- JBTM Nasdaq
- TECH Nasdaq
- Market Cap
- JBTM 6.9B
- TECH 7.8B
- IPO Year
- JBTM N/A
- TECH 1989
- Fundamental
- Price
- JBTM $147.76
- TECH $57.09
- Analyst Decision
- JBTM Strong Buy
- TECH Buy
- Analyst Count
- JBTM 2
- TECH 12
- Target Price
- JBTM $143.00
- TECH $69.82
- AVG Volume (30 Days)
- JBTM 523.9K
- TECH 2.2M
- Earning Date
- JBTM 08-04-2025
- TECH 08-06-2025
- Dividend Yield
- JBTM 0.27%
- TECH 0.56%
- EPS Growth
- JBTM N/A
- TECH N/A
- EPS
- JBTM N/A
- TECH 0.46
- Revenue
- JBTM $2,710,300,000.00
- TECH $1,219,635,000.00
- Revenue This Year
- JBTM $117.13
- TECH $7.33
- Revenue Next Year
- JBTM $4.51
- TECH $9.32
- P/E Ratio
- JBTM N/A
- TECH $124.26
- Revenue Growth
- JBTM 64.98
- TECH 5.23
- 52 Week Low
- JBTM $82.64
- TECH $46.01
- 52 Week High
- JBTM $148.53
- TECH $80.95
- Technical
- Relative Strength Index (RSI)
- JBTM 65.92
- TECH 60.85
- Support Level
- JBTM $137.66
- TECH $53.89
- Resistance Level
- JBTM $140.99
- TECH $54.95
- Average True Range (ATR)
- JBTM 4.29
- TECH 1.93
- MACD
- JBTM 0.16
- TECH 0.25
- Stochastic Oscillator
- JBTM 93.51
- TECH 96.52
About JBTM JBT Marel Corporation
JBT Marel Corp is a technology solutions provider to segments of the food and beverage industry. It designs, produces, and services products and systems for a broad range of end markets, generating roughly one-half of annual revenue from recurring parts, services, rebuilds, and leasing operations.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.